<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/allregs/css/uswds.min.css">
    <link rel="stylesheet" href="/allregs/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/allregs/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/allregs/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/parts/21CFR520.html">Part 520
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 520.1196  Ivermectin and pyrantel tablets.
                            </h3>
                            <p class="depth1"><em>(a)</em> Specifications. Each chewable tablet contains either 68 micrograms ([micro]g) of ivermectin and 57 milligrams (mg) of pyrantel (as pamoate salt), or 136 [micro]g and 114 mg, or 272 [micro]g and 227 mg, respectively.</p><p class="depth1"><em>(b)</em> Sponsors. See Nos. 050604, 051311, and 063604 in Sec. 510.600(c) of this chapter.</p><p class="depth1"><em>(c)</em> Conditions of use--(1) Dogs--(i) Amount. Administer a minimum of 6 [micro]g of ivermectin and 5 mg of pyrantel per kilogram (2.72 [micro]g and 2.27 mg per pound) of body weight monthly.</p><p class="depth2"><em>(1)</em> Dogs--(i) Amount. Administer a minimum of 6 [micro]g of ivermectin and 5 mg of pyrantel per kilogram (2.72 [micro]g and 2.27 mg per pound) of body weight monthly.</p><p class="depth3"><em>(i)</em> Amount. Administer a minimum of 6 [micro]g of ivermectin and 5 mg of pyrantel per kilogram (2.72 [micro]g and 2.27 mg per pound) of body weight monthly.</p><p class="depth3"><em>(ii)</em> Indications for use. To prevent canine heartworm disease by eliminating the tissue larval stages of Dirofilaria immitis for up to a month (30 days) after infection and treatment and control of adult ascarids Toxocara canis and Toxascaris leonina, and adult hookworms Ancylostoma caninum, A. braziliense, and Uncinaria stenocephala.</p><p class="depth3"><em>(iii)</em> Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.</p><p class="depth2"><em>(2)</em> [Reserved]
[58 FR 8542, Feb. 16, 1993, as amended at 61 FR 15186, Apr. 5, 1996; 61 FR 59004, Nov. 20, 1996; 62 FR 63270, Nov. 28, 1997; 66 FR 35756, July 9, 2001; 67 FR 21996, May 2, 2002; 68 FR 55823, Sept. 29, 2003; 78 FR 28822, May 20, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
